Cargando…
EBOLA and FDA: reviewing the response to the 2014 outbreak, to find lessons for the future
In 2014, West Africa confronted the most severe outbreak of Ebola virus disease (EVD) in history. At the onset of the outbreak—as now—there were no therapies approved by the U.S. Food and Drug Administration (FDA) for prevention of, post-exposure prophylaxis against, or treatment of EVD. As a result...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570698/ https://www.ncbi.nlm.nih.gov/pubmed/28852537 http://dx.doi.org/10.1093/jlb/lsw046 |